nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cells
|
Borges, Sahra |
|
2014 |
144 |
1 |
p. 79-91 |
artikel |
2 |
Analyzing factors associated with women’s attitudes and behaviors toward screening mammography using design-based logistic regression
|
Madadi, Mahboubeh |
|
2014 |
144 |
1 |
p. 193-204 |
artikel |
3 |
Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
|
Zhai, Zanjing |
|
2014 |
144 |
1 |
p. 33-45 |
artikel |
4 |
Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer
|
Pud, Dorit |
|
2014 |
144 |
1 |
p. 123-131 |
artikel |
5 |
Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients
|
Wong, A. L. |
|
2014 |
144 |
1 |
p. 143-152 |
artikel |
6 |
Diallyl trisulfide inhibits estrogen receptor-α activity in human breast cancer cells
|
Hahm, Eun-Ryeong |
|
2014 |
144 |
1 |
p. 47-57 |
artikel |
7 |
Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study
|
Kharazmi, Elham |
|
2014 |
144 |
1 |
p. 185-192 |
artikel |
8 |
Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1
|
Dowty, J. G. |
|
2014 |
144 |
1 |
p. 171-177 |
artikel |
9 |
Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
|
Fuqua, Suzanne A. W. |
|
2014 |
144 |
1 |
p. 11-19 |
artikel |
10 |
Ex vivo Evans blue assessment of the blood brain barrier in three breast cancer brain metastasis models
|
Do, John |
|
2014 |
144 |
1 |
p. 93-101 |
artikel |
11 |
Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status
|
Nilsson, Martin P. |
|
2014 |
144 |
1 |
p. 133-142 |
artikel |
12 |
Mammographic screening detects low-risk tumor biology breast cancers
|
Drukker, C. A. |
|
2014 |
144 |
1 |
p. 103-111 |
artikel |
13 |
α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma
|
Ito, Masaoki |
|
2014 |
144 |
1 |
p. 59-69 |
artikel |
14 |
Providers of follow-up care in a population-based sample of breast cancer survivors
|
Friese, Christopher R. |
|
2014 |
144 |
1 |
p. 179-184 |
artikel |
15 |
Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the “biological window therapy”
|
Foroni, Chiara |
|
2014 |
144 |
1 |
p. 113-121 |
artikel |
16 |
Reproductive risk factors and breast cancer subtypes: a review of the literature
|
Anderson, Kristin N. |
|
2014 |
144 |
1 |
p. 1-10 |
artikel |
17 |
Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma
|
Loibl, Sibylle |
|
2014 |
144 |
1 |
p. 153-162 |
artikel |
18 |
Risk of cardiovascular adverse events from trastuzumab (Herceptin®) in elderly persons with breast cancer: a population-based study
|
Tsai, H.-T. |
|
2014 |
144 |
1 |
p. 163-170 |
artikel |
19 |
Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients
|
Miller, Cynthia L. |
|
2014 |
144 |
1 |
p. 71-77 |
artikel |
20 |
Sclerosing adenosis and risk of breast cancer
|
Visscher, Daniel W. |
|
2014 |
144 |
1 |
p. 205-212 |
artikel |
21 |
Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review
|
Verbelen, Hanne |
|
2014 |
144 |
1 |
p. 21-31 |
artikel |